We have now published our latest Market Movers update on the CHC Dashboard website, highlighting 6 brands that have been driving growth in the global CHC market in the MAT Q3 2020 period, as well as 6 brands in fast decline, and below we look at the trends behind these exceptional brand performances.
As was the case in MAT Q2 2020, a common thread among the fastest-growing brands is immunity positioning, with four of the six products highlighted below – Dabur Chyawanprash (India), Yiling Lianhua Qingwen (China), Airborne (USA) and Arbidol (Russia) – boosted by heightened consumer demand during the pandemic for products that boost immunity.
Germ-X (Vi-Jon) is a new entry in the Top 6 fastest-growing brands, and one of several antiseptics & disinfectants that posted a steep rise in growth in the year to end-September 2020, along with ArtNaturals (ArtNaturals) and Suave (Unilever) in the US market and Dettol (RB) in China. Meanwhile, global No.2 CHC brand Tylenol (J&J) continued to close in on global No.1 Vicks (P&G) with dynamic growth (+30%) in the USA, boosted by Covid-related demand for painkillers and innovation, notably the Q2 2020 launch of Tylenol Extra Strength Dissolve Packs.
Ayurvedic formulation Dabur Chyawanprash (Dabur) saw sales more than double (+155%) in MAT Q3 2020, driven by strong Covid-related demand and the launch of Dabur Immunity Kit in Q2 2020, and has established itself as India’s No.1 CHC brand. Likewise, umifenovir-based medicine Arbidol (OTCPharm), which is positioned for flu as well as acute respiratory and viral infections, saw sales more than treble (+206%) in the MAT Q3 2020 period and has now become the No.1 CHC brand in Russia.
As for products that suffered falling sales in MAT Q3 2020, again the notable examples were tonics & cure alls in China – such as Dong-e E-Jiao – hit by rising raw material costs and falling demand, as well as ranitidine-based antacids – such as Sanofi’s Zantac 150 – owing to concerns around NDMA and Takeda’s Alinamin EX vitamin B supplement in Japan, affected by demographic changes and a fall in tourist spending.
You can review various NPD trends in our report from CHC New Products Tracker, Innovation in CHC. This report highlights the best innovations from 2019, looks at innovation by region and country, plus much more. For more information, or to order your copy, available with a 30% discount until 31 December, please contact melissa.lee@NicholasHall.com